Hsbc Holdings PLC Tiziana Life Sciences LTD Call Options Transaction History
Hsbc Holdings PLC
- $168 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TLSA
# of Institutions
33Shares Held
993KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA246KShares$319,4380.0% of portfolio
-
Morgan Stanley New York, NY111KShares$144,0800.0% of portfolio
-
Zhang Financial LLC96.3KShares$125,1380.01% of portfolio
-
Kovitz Investment Group Partners, LLC79.4KShares$103,1740.0% of portfolio
-
Ewa, LLC Pittsbugh, PA47.6KShares$61,8810.02% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $133M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...